Avanos Medical, Inc. (AVNS)
NYSE: AVNS · IEX Real-Time Price · USD
21.92
-0.52 (-2.32%)
Jul 22, 2024, 10:14 AM EDT - Market open

Avanos Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2012
Cash & Equivalents
75.887.7127.7118.5111.5205.3
Upgrade
Cash & Cash Equivalents
75.887.7127.7118.5111.5205.3
Upgrade
Cash Growth
-20.79%-31.32%7.76%6.28%-45.69%-46.61%
Upgrade
Receivables
131.3142.8167.9131.2108.6152.4
Upgrade
Inventory
165.6163.2132.3159.3168.9145.9
Upgrade
Other Current Assets
95.193.3196.218.678.234.9
Upgrade
Total Current Assets
467.8487624.1427.6467.2538.5
Upgrade
Property, Plant & Equipment
140.4144146.1206.7223.6248.5
Upgrade
Goodwill and Intangibles
1,0281,036994.5942.8960.2985.2
Upgrade
Other Long-Term Assets
25.425.822.226.521.827.4
Upgrade
Total Long-Term Assets
1,1941,2051,1631,1761,2061,261
Upgrade
Total Assets
1,6611,6921,7871,6041,6731,800
Upgrade
Accounts Payable
5756.367.956.467.683
Upgrade
Current Debt
20.921.418.214.715.514.7
Upgrade
Other Current Liabilities
127.3156.9104.968.183.2114.8
Upgrade
Total Current Liabilities
205.2234.6191139.2166.3212.5
Upgrade
Long-Term Debt
193.8187.7258.8172.8233.3310.7
Upgrade
Other Long-Term Liabilities
34.433.845.92116.711.2
Upgrade
Total Long-Term Liabilities
228.2221.5304.7193.8250321.9
Upgrade
Total Liabilities
433.4456.1495.7333416.3534.4
Upgrade
Total Debt
214.7209.1277187.5248.8325.4
Upgrade
Debt Growth
-15.94%-24.51%47.73%-24.64%-23.54%31.37%
Upgrade
Retained Earnings
-315.8-314.9-253.1-303.6-315.5-288.3
Upgrade
Comprehensive Income
-29.5-27-35.8-33.8-28.1-32
Upgrade
Shareholders' Equity
1,2281,2361,2911,2711,2571,265
Upgrade
Net Cash / Debt
-138.9-121.4-149.3-69-137.3-120.1
Upgrade
Working Capital
262.6252.4433.1288.4300.9326
Upgrade
Book Value Per Share
26.5826.6327.7726.3726.2726.40
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).